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Nicotiana tabacum Bright Yellow-2 (BY-2) suspension cells are among the most
commonly used plant cell lines for producing biopharmaceutical glycoproteins.
Recombinant glycoproteins are usually produced with a mix of high-mannose and
complex N-glycans. However, N-glycan heterogeneity is a concern for the production
of therapeutic or vaccine glycoproteins because it can alter protein activity and
might lead to batch-to-batch variability. In this report, a BY-2 cell line producing
glycoproteins devoid of complex N-glycans was obtained using CRISPR/Cas9 edition
of two N-acetylglucosaminyltransferase I (GnTI) genes, whose activity is a prerequisite
for the formation of all complex N-glycans. The suppression of complex N-glycans
in the GnTI-knocked out (KO) cell lines was assessed by Western blotting. Lack of
β1,2-xylose residues confirmed the abolition of GnTI activity. Unexpectedly, α1,3-fucose
residues were still detected albeit dramatically reduced as compared with wild-type
cells. To suppress the remaining α1,3-fucose residues, a second genome editing
targeted both GnTI and α1,3-fucosyltransferase (FucT ) genes. No β1,2-xylose nor
α1,3-fucose residues were detected on the glycoproteins produced by the GnTI/FucT-
KO cell lines. Absence of complex N-glycans on secreted glycoproteins of GnTI-KO
and GnTI/FucT-KO cell lines was confirmed by mass spectrometry. Both cell lines
produced high-mannose N-glycans, mainly Man5 (80 and 86%, respectively) and Man4
(16 and 11%, respectively). The high degree of N-glycan homogeneity and the high-
mannose N-glycosylation profile of these BY-2 cell lines is an asset for their use as
expression platforms.
Keywords: glyco-engineering, plant suspension cells, oligomannose N-glycans, CRISPR/Cas9, molecular
farming, N-acetylglucosaminyltransferase I, α1,3-fucosyltransferase
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INTRODUCTION
Developing a recombinant glycoprotein production platform in
plants with simplified and homogenized N-glycan repertoire
represents a key step to design new, highly efficient vaccines and
therapeutic glycoproteins. Indeed, production of recombinant
glycoproteins usually results in a mix of glycoforms that can
display different levels of activity or immunogenicity (Sola and
Griebenow, 2010; Lavine et al., 2012; Hariharan and Kane, 2020).
Identifying and expressing the most efficient glycoforms could
also improve the quality of the product as well as simplify the
control of batch-to-bach reproducibility. Impairing the synthesis
of complex N-glycans, responsible for most of the N-glycan
diversity, in order to produce only high-mannose N-glycans
(Man4–Man9) is a powerful strategy to homogenize the N-glycan
repertoire. N-acetylglucosaminyltransferase I (GnTI) is a key
Golgi-resident enzyme essential for the processing of high-
mannose to hybrid and complex N-glycans (Supplementary
Figure 1). GnTI transfers an N-acetylglucosamine (GlcNAc)
residue from UDP-GlcNAc to the acceptor substrate Man5 to
produce GnMan5, which is a prerequisite for the subsequent
action of all other processing enzymes (Strasser, 2016). The
GnTI single-pass transmembrane domain is responsible for the
steady-state distribution in the cis/medial-Golgi (Essl et al.,
1999; Schoberer et al., 2014, 2019). Since GnTI is required
to generate all complex N-glycans, inactivation of GnTI in
plants has been carried out. It allows N-glycan repertoire
simplification of produced recombinant glycoproteins and also
the suppression of all non-human residues, i.e., β1,2-xylose and
α1,3-fucose found on complex N-glycans. Another approach
to produce recombinant glycoproteins with unprocessed high-
mannose N-glycans is to prevent trafficking through the
Golgi by the addition of a C-terminal H/KDEL sequence
(Fujiyama et al., 2009).
The first GnTI mutants in plants were isolated in Arabidopsis
thaliana from a pool of random mutagenized seeds (von
Schaewen et al., 1993). The complex glycan-less1 allele 1 (cgl1-
1) mutant lacks GnTI activity and cDNA sequencing identified
the point mutation Asp144Asn, which introduced an extra
N-glycosylation site impairing the GnTI folding (Strasser et al.,
2005; Frank et al., 2008). Early reports of the cgl1-1 mutant
did not detect any complex N-glycans on glycoproteins of
plant extracts, with the predominant type of glycans being
Man5 (75%) (Strasser et al., 2005). However, the cgl1-1 mutant
enzyme recovers its activity when the wrong N-glycosylation
site is skipped (e.g., under stress, in certain developmental
stages, or in the stt3a background, for the latter see Frank
et al., 2008). A. thaliana cgl1-1 plants growth and morphology
were not affected under normal conditions but were more
impacted by salt stress than wild-type (WT) plants (Kang et al.,
2008). A decrease in photosynthetic capacity of the cgl1-1
mutant was also reported (Jiao et al., 2020). Many enzymes
used as therapeutics for lysosomal storage diseases require
phosphorylated high-mannose N-glycans for their targeting
to the lysosomes (Grubb et al., 2010). Hence, the human
lysosomal enzymes glucocerebrosidase and α-L-iduronidase were
produced in cgl1-1 seeds and showed a large proportion
of high-mannose-type N-glycans (85–94%), predominantly
Man5. Nonetheless, significant amounts of MMXF (9–3.8%),
Man5F (3.1–0.4%), GnMXF (2.7–0%) or MMX(0–1.3%) on
specific N-sites were also produced, suggesting the presence
of a residual GnTI activity in these seeds (He et al., 2011,
2013; Pierce et al., 2017). The cgl1-2 mutant (translational
frameshift) also lacked GnTI activity (von Schaewen et al.,
1993; Frank et al., 2008). Analysis of the activation associated
secretory protein 1 produced in cgl1-2 seeds showed only high-
mannose glycans (Piron et al., 2015), suggesting a total loss of
GnTI activity.
The rice gnt1 mutant line (SAI3G12) contains a T-DNA
insertion in the sixth exon/intron junction of GnTI leading to
the absence of native GnTI transcripts (Fanata et al., 2013). As a
result, only high-mannose N-glycans were identified. In contrast
with the A. thaliana cgl1 mutants, rice gnt1 plants displayed
a severe growth phenotype, resulting in early lethality under
normal culture conditions. These plants showed a reduction in
the cell wall thickness and cellulose content and were insensitive
to cytokinin signaling. A rice suspension line was derived from
a gnt1 plant and used to produce the recombinant human acid
α- or β-glucosidase. Only mannosylated N-glycans were detected
on the two recombinant proteins secreted in the culture medium,
with a high proportion of Man5 (58% for α-glucosidase and 80%
for β-glucosidase) (Jung et al., 2017, 2019).
Several mutants in key enzymes of the N-glycosylation
pathway were selected from the Lotus japonicus retrotransposon
1 insertion population (Pedersen et al., 2017). The Ljgnt I
mutated plants showed a severely altered growth phenotype, as
they predominantly died before the flowering stage. Minimizing
the biotic and abiotic stress increased the number of Ljgnt I
mutants entering the reproduction stage. These results confirmed
the differences in tolerance to GnTI inactivation between plant
species and highlighted the implication of complex N-glycans in
stress resistance.
GnTI knock down in Nicotiana benthamiana plants were
generated in two different studies by RNAi-mediated silencing.
In the first one, GnTI activity was below the detection limit (3%)
in one line but sufficient for the synthesis of complexN-glycans in
amounts comparable to WT plants as no impact on the N-glycan
repertoire was observed. Complex N-glycans still accounted for
80% of total N-glycans (Strasser et al., 2004a). It was hypothesized
that low GnTI expression and activity were sufficient to maintain
complex N-glycans synthesis. On the other hand, transgenic
plants showing a strong reduction in complex N-glycans
abundance (with only 9% of all N-glycan structures as compared
to 89% in WT plants) were obtained in the second study (Limkul
et al., 2016). No altered growth phenotype was observed in those
plants when compared to WT plants. Glycoproteomics analysis
of the purified glucocerebrosidase expressed in this mutant
background showed a large proportion of high-mannose-type
N-glycans (73–85%), predominantly Man5, on the four N-sites,
but also the presence of significant amounts of paucimannose
N-glycans with β1,2-xylose and α1,3-fucose residues, suggesting
a residual GnTI activity (Limkul et al., 2015, 2016).
Reduction of NtGnTI activity in Nicotiana tabacum was
obtained by gene silencing using the antisense technology
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and evaluated by immunoblot analysis using a complex
glycan antiserum on leaf extracts. Transformants showed
substantial reduction in complex glycan detection compared
with untransformed controls but the reduction of intensity
varied according to the leaf age and developmental stage
(Wenderoth and von Schaewen, 2000).
Preventing GnTI expression in plants thus results in altered
phenotype at least under stress conditions. Suspension cells
might offer an interesting alternative for the expression of
recombinant glycoproteins. N. tabacum Bright Yellow-2 (BY-2)
suspension cells are characterized by a short culture cycle, easy
scaling up in bioreactors, low risk of contamination by human
pathogens and the possibility to purify secreted recombinant
proteins directly from the culture medium (Tekoah et al., 2015;
Santos et al., 2016). BY-2 cells have already been used to express
several pharmaceutical glycoproteins such as antibodies (De
Muynck et al., 2009; Holland et al., 2010; Magy et al., 2014), a
viral glycoprotein (Smargiasso et al., 2019) or human enzymes
(Hanania et al., 2017; Ilan et al., 2017). In this study, we report
on the identification and characterization of two GnTI genes in
the N. tabacum BY-2 genome. Both were inactivated through a
multiplex CRISPR/Cas9 gene edition, which resulted in the non-
detection of complex N-glycans to the benefit of high-mannose
N-glycans, mainly the glycoform Man5. However, traces of
α1,3-fucose residues were detected on glycoproteins by Western
blotting. To eliminate thoroughly this non-human residue,
GnTI and fucosyltransferase (FucT) genes were inactivated
simultaneously. This combined inactivation resulted in a BY-2
cell line with high-mannose N-glycans and no detectable α1,3-
fucose. Generation of this BY-2 cell line capable of producing
glycoproteins with a high-mannose profile is a powerful tool to
improve our understanding of the impact of those N-glycans on
the properties of vaccinal and biotherapeutic glycoproteins.
MATERIALS AND METHODS
N. tabacum BY-2 Cell and Nicotiana
Plants Culture
N. tabacum cv. BY-2 suspension cells (Nagata et al., 1992) were
grown in the dark at 25◦C with agitation on a rotary shaker
(90 rpm) in liquid MS medium [4.4 g/L Murashige and Skoog
salts (MP BIOMEDICALS, Solon, OH, United States), 30 g/L
sucrose, 0.2 g/L KH2PO4, 2.5 mg/L thiamine, 50 mg/L myo-
inositol, and 0.2 mg/L 2,4-dichlorophenoxyacetic acid, pH 5.8
(KOH)]. Cultures were grown in 50 mL of medium in a 250 mL
Erlenmeyer flask and an 8% inoculum was transferred each week
into fresh medium. Transformed cells were grown on MS agar
plates supplemented with 100 µg/mL kanamycin. Samples used
for genomic analyses and Western blot screening were harvested
from liquid cultures obtained after at least two passages on solid
selective medium (1–2 months) and at least two passages in liquid
selective medium. Lines used for MS analyses were checked by
Western blotting and the same profile was invariably observed.
Nicotiana tomentosiformis, N. sylvestris, and N. tabacum seeds
were purchased from Bergerac Seed and Breeding. They were
germinated and grown in soil under controlled conditions (25◦C,
16 h photoperiod).
Extraction of Genomic DNA
Genomic DNA was extracted from 7-day-old BY-2 cells
filtered on four layers of Miracloth (Calbiochem) or
from plant leaf material using the Wizard Genomic DNA
Purification Kit (Promega).
Characterization of GnTI Orthologs and
Analysis of Genome Modifications
Genomic DNA was amplified by PCR using Q5 High-Fidelity
DNA Polymerase (New England Biolabs) and the primers listed
in Supplementary Table 1. The PCR products were separated by
gel electrophoresis on 1% agarose gel, purified, cloned into the
pGEM-T Easy vector (Promega), and sequenced.
RNA Extraction and RT-PCR
RNA extraction was carried out using the Spectrum Plant Total
RNA Kit (Sigma). cDNAs were obtained using M-MLV Reverse
Transcriptase (Promega). PCR amplification was performed with
Q5 High-Fidelity DNA Polymerase (New England Biolabs) and
the primers listed in Supplementary Table 1. PCR products were
purified and sequenced.
GnTI and FucT Gene Accessions
GenBank mRNA accessions are: NtGnTI.A (AJ249882), NtGnTI.B
(AJ249883), NsGnTI (XM_009803697 and XM_009776507),
NtoGnTI (XM_009610507), FucTA (XM_016657530), FucTB
(XM_016620229), FucTC (NM_001324945), and FucTD
(XM_016585847).
Cas9 and gRNA Binary Plasmid
Construction
The four guide RNAs (gRNAs) targeting GnTI were obtained
by fusing the CRISPR RNA (crRNA) sequence (Supplementary
Table 2) to the trans-activating crRNA (tracrRNA) optimized
by Dang et al. (2015). These gRNAs target exons 1, 3, 13,
and 14 at sites conserved in all identified transcript variants of
the two NtGnTI orthologs. crRNAs were chosen to minimize
the risk of off-targets using the Cas-OFFinder tool (Bae et al.,
2014). Moreover, crRNAs with high minimum free energy (−1
to 0 kcal/mol) were selected since crRNA secondary structures
can greatly hinder edition efficiency. A transfer RNA (tRNA)
was placed before each gRNA to generate a polycistronic tRNA-
gRNA (PTG) under the control of the A. thaliana U6 promoter
(Xie et al., 2015).
The polycistronic tRNA-gRNA targeting GnTI (GnTI.PTG)
flanked with StuI and XhoI restriction sites, was synthesized
(Genscript) and cloned into a pUC57 vector. The FucT/XylT.PTG
of pPAM-FX-KO (Jansing et al., 2019) was replaced by the
GnTI.PTG using StuI-XhoI digestion to generate the pPAM-
GnTI-KO plasmid, which also contains a plant codon optimized
cas9 with a potato IV2 intron controlled by a hybrid 35SPPDK
promoter (Li et al., 2013) and the selectable marker gene
nptII (Figure 1A). Cassettes are separated from each other by
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FIGURE 1 | Schematic representation of the two plant transformation vectors. (A) pPAM-GnTI-KO (B) pPZP-GnTI/FucT-KO. SAR, N. tabacum Rb7 scaffold
attachment region (genetic insulator); nptII, neomycin phosphotransferase II; pcoCas9, plant codon-optimized cas9; PTG, polycistronic tRNA-gRNA; codA, cytosine
deaminase A.
a N. tabacum Rb7 scaffold attachment region (SAR) genetic
insulator. Complete sequence between left and right borders is
given in Supplementary Figure 2.
To generate GnTI/FucT-KO cell lines, a pPZP-RCS2 binary
plasmid (Goderis et al., 2002) containing the knockout constructs
was prepared (Figure 1B). The pPZP-GnTI/FucT-KO contains
pcocas9, nptII, mCherry reporter gene, the negative selectable
marker cytosine deaminase A (Stougaard, 1993), the two
PTG and loxP sites at both ends of the T-DNA. GnTI.PTG
obtained above and FucT.PTG (Mercx et al., 2017) were
cloned into I-CeuI and PI-PspI restriction sites, respectively.
Complete sequence between left and right borders is given in
Supplementary Figure 3.
BY-2 Cell Transformation
Biolistic particle delivery was carried out with the plasmid
pPAM-GnTI-KO. Four milliliters of three-day-old BY-2 cells were
vacuum filtered on a Whatman n◦4 filter and the cells were
transferred on solid MS medium. The next day, plasmid DNA
(2 µg) was precipitated on 600 µg of 0.6 µm diameter gold beads
(Bio-Rad) and the cells on the filter were bombarded under a 28-
inch Hg vacuum (95 kPa), using a 1,100 PSI (7,600 kPa) rupture
disk, at a shooting distance of 4 cm with a Biolistic PDS1000/He
device (Bio-Rad). The filter was kept on solid MS medium for
three days at 25◦C under dark conditions. Filters were then
transferred onto kanamycin-supplemented MS medium. After
four to five weeks, the growing calli were transferred on new solid
kanamycin-supplemented MS medium.
Agrobacterium tumefaciens LBA4404VirG-mediated
transformation of BY-2 cells was carried out with the plasmid
pPZP-GnTI/FucT-KO as described in Navarre et al. (2006).
SDS-PAGE and Western Blotting
Analysis of Proteins
For extracellular protein glycosylation analysis by Western
blot, 2 mL of a 7-day-old BY-2 culture in MS medium
were filtered on three layers of Miracloth (Calbiochem) and
40 µL of the filtrate were directly analyzed by reducing
SDS-PAGE. Filtered BY-2 cells were used to harvest total
soluble cellular proteins (TSCPs). Cell packs were transferred
into a 2 mL micro tube (Sarstedt) containing 0.5 g of glass
beads (0.85–1.23 mm) and 700 µL of homogenization buffer
(250 mM sorbitol, 60 mM Tris–HCl, 2 mM Na2EDTA, pH 8.0)
supplemented with 1 mM phenylmethylsulfonylfluoride (PMSF),
and protease inhibitor cocktail (leupeptin, aprotinin, antipain,
pepstain, and chymostain, each at 2 µg/mL). Cell grinding
was performed for 3 × 40 s at 5,000 rpm (PrecellysTm24
Control Device, Bertin Technologies) with 2 min pauses on
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ice. The samples were centrifuged first for 5 min at 5,000 rpm
at 4◦C (Eppendorf Centrifuge 5417C), then for 7 min at
9,400 rpm at 4◦C, and finally for 15 min at 54,000 rpm at
4◦C (Optima MAX ultracentrifuge, Beckman Coulter). The
protein concentration in the supernatant was quantified by
Bradford assay and 12 µg TSCP were analyzed by reductive
SDS-PAGE (4–20% polyacrylamide). Gels were either stained
with Coomassie Brilliant Blue G-250 (SERVA, Heidelberg,
Germany) or transferred onto a PVDF membrane (Millipore,
Billerica, MA, United States) for Western blotting. The PVDF
membrane was incubated with the primary antibodies against
β1,2-xylose (monoclonal antibody, Agrisera AS07 267; dilution
1:5,000) or α1,3-fucose (monoclonal antibody, Agrisera AS07
268; dilution 1:5,000) or a mix of both. Secondary horseradish
peroxidase (HRP)-conjugated antibodies against rabbit IgG
(dilution 1:10,000) were used for extracellular proteins samples.
The signals were analyzed using a Kodak Image Station 4000R
(Eastman Kodak company, Rochester, NY, United States).
HRP-conjugated antibodies were not used for TSCP analysis
because of a strong signal attributed to intracellular endogenous
peroxidase activity. Rather, secondary alkaline phosphatase-
conjugated antibodies against rabbit IgG (dilution 1:10,000)
were used.
Sample Preparation for MALDI Mass Spectrometry
N-Glycan Identification
For the mass spectrometry analysis, cultures were grown in liquid
D11b medium (Vasilev et al., 2013) without cyclodextrin for
10 days in 50 mL of medium in 250 mL Erlenmeyer flasks.
Extracellular proteins were collected by filtration on three layers
of Miracloth (Calbiochem), then centrifuged at 8,000 g for
30 min, and precipitated by salting-out as previously described
in Smargiasso et al. (2019) with the following minor adaptations:
solid (NH4)2SO4 was slowly added to the culture medium with
stirring at room temperature to 55% saturation and the solution
was then kept for 2 h at 4◦C and centrifuged at 3,000 g for 40 min
at 4◦C. The pellet was solubilized in 140 µL of PBS buffer and
desalted on a PD-10 filtration column (GE Healthcare, Uppsala,
Sweden) equilibrated with PBS buffer.
Ribonuclease B from bovine pancreas was used as a positive
control sample and was prepared using the same procedure as
for the glycoprotein samples from BY-2 cells. The samples were
first centrifuged at 8,000 g for 5 min at 4◦C, the supernatant was
filtered on Amicon 3 kDa and the protein content assessed using
the RC DC protein essay kit (Bio-Rad). Reduction of 350 µg
proteins was performed in 50 mM (NH4)2CO3 and 10 mM of
dithiothreitol at 56◦C for 40 min at 650 rpm in a thermoshaker.
Then alkylation of cysteinyl residues was performed using 20 mM
C2H4INO at RT for 40 min at 650 rpm using a thermoshaker.
2D clean up purification kit (GE Healthcare Life Sciences) was
used while the extra washing step (using wash additive) was
skipped. Pellets containing proteins were resolubilized in 50 mM
(NH4)2CO3 (pH 7.5) before trypsin digestion (protein:trypsin
ratio of 50:1) at 37◦C for 16 h at 600 rpm. The samples were
freeze-dried using SpeedVac centrifugal evaporator and a second
trypsin digestion was performed at 37◦C in 80% acetonitrile
using 100:1 protein:trypsin ratio for 3 h at 600 rpm. Trypsin was
inactivated at 90◦C for 2 min.
In order to guarantee the removing of all N-glycans of interest,
a two-step enzymatic release of the N-glycans was performed
on the trypsin digested samples using first 3 U per 100 µg
proteins of PNGase F (Roche, discontinued product) dissolved in
50 mM (NH4)2CO3 (pH 8) at 37◦C for 16 h. Samples were freeze-
dried and resolubilized in 48.3 mM C6H8O7 and 103.3 mM
NaH2PO4.H2O buffer (pH 5). The second deglycosylation step
was performed with 0.2 mU of PNGase A (Roche, discontinued
product) per 100 µg proteins at 37◦C for 16 h at 650 rpm. Samples
were stored at −20◦C after freeze-drying using a SpeedVac
centrifugal evaporator.
The N-glycans fraction was separated from the peptide
fraction using Waters Sep-Pack SPE C18 cartridges after being
reconditioned using 5 mL of pure methanol, then 5 mL of
5% acetic acid, 5 mL of pure isopropanol and finally 15 mL
of 5% acetic acid. Samples were loaded on the cartridge after
solubilizing the dried residue in 200 µL of 5% acetic acid.
N-glycans were eluted in the 3 mL of 5% acetic acid mobile
phase. All the samples were freeze-dried and kept at −20◦C. The
N-glycans containing fraction was desalted using H-cartridges
(PROzyme, Agilent) after being reconditioned following the
manufacturer recommendations. Desalted N-glycans elution was
performed as follows: 3 mL of ultrapure water (discarded), 3 mL
of 5% acetonitrile and 0.1% trifluoroacetic acid (discarded), and
4 × 0.5 mL of 50% acetonitrile and 0.1% trifluoroacetic acid.
These collected fractions were freeze-dried and kept at−20◦C.
The labeling of N-glycans was then performed using a mixture
of 31.5 mg of 2-aminobenzamide (2-AB) and 31.5 mg of
NaBH3CN in 650 µL of 10 volumes DMSO: 3 volumes glacial
acetic acid. Ten microliters of this mixture was added to the
dried N-glycan fraction and incubated for 2 h at 65◦C under
1,200 rpm agitation using a thermoshaker. The 2-AB labeled
N-glycans were purified using S-cartridges (PROzyme, Agilent)
following the manufacturer recommendations and eluted using
3 × 0.5 mL of ultrapure water in Pyrex tubes. The samples were
freeze-dried using centrifugal evaporator and kept at−20◦C.
MALDI-mass spectrometry identification of 2-AB labeled
N-glycans
The purified 2-AB labeled N-glycans were resolubilized in
10 µL of 50% acetonitrile spiked with 0.1% formic acid and
vigorous vortexed in 0.6 mL Eppendorf tube. One microliter
of 2-AB labeled N-glycan and 1 µL of 2,5-dihydroxybenzoic
acid solution (20 mg/mL of 2,5-dihydroxybenzoic acid in 50%
acetonitrile and 0.1% formic acid) were mixed and spotted
(dried-droplet method) on a MALDI plate Anchorchip384BC
fitted on its plate adapter (Bruker) and dried at RT. MALDI
mass spectra were obtained using a SolariX XR 9.4T FT-ICR
(Bruker) fitted with the dual ESI/MALDI source and Smartbeam
LASER. The mass range was set from 150 to 3,500 m/z using 4
megawords acquisition, resulting in an average mass resolving
power (FWMH) of about 150,000 at m/z ≈1,100. Two hundred
laser shots per scan in small focus mode were selected at the
rate of 2,000 Hz. Red P (Sladkova et al., 2009) was used to
optimize the ion transmission of m/z going from 800 to 3,000.
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The MALDI FT-ICR was mass calibrated using Red P and the
peptide calibration standard II (Bruker). Mass calibration was
checked using the m/z determination of high mannose N-glycans
released from ribonuclease B. Several replicates of mass spectra
were acquired using 12 scan accumulation mode to attempt the
detection of minor N-glycans. The data were manually processed
using DataAnalysis v5.0 software (Bruker). Only peaks with
an intensity higher than 1.4 × 106 were considered. The ion
mass lists were manually generated based on the GlycoMod tool
(Cooper et al., 2001, 2003) using proton and sodium adducts as
potentially detected N-glycans1. Mass accuracy (0.1 Da) was used





Genes in N. tabacum
N. tabacum is an allotetraploid species resulting from the cross
between N. tomentosiformis and N. sylvestris (Yukawa et al.,
2006). The NtGnTI orthologs derived from N. tomentosiformis
and N. sylvestris will be referred to as NtGnTI.A and NtGnTI.B,
respectively, nomenclature previously proposed for NtSBT1
genes (Navarre et al., 2012), and NtFucT or NtXylT genes
(Mercx et al., 2017). The NtGnTI.A and NtGnTI.B cDNAs have
already been identified from N. tabacum cDNA leaf libraries
(Strasser et al., 1999; Wenderoth and von Schaewen, 2000). Blast
analysis on the four N. tabacum genome assemblies (TN90,
BX, K326, and Nitab 4.5) as well as the N. tomentosiformis
and N. sylvestris genomes2 identified the GnTI.A full-length
gene in all four N. tabacum cultivars (Ntab-TN90_AYMY-
SS16267) and in N. tomentosiformis (Ntom_KB953441.1). On
the other hand, the GnTI.B gene was found to be split
into three contigs in N. tabacum TN90 and BX cultivars
(Ntab-TN90_AYMY-SS68155: exons 1-11, Ntab-TN90_AYMY-
SS133799: exon 12-18, Ntab-TN90_AYMY-SS242176: exon 19),
and in two contigs in N. sylvestris (Nsyl_KD955459.1: exons
1-11 and Nsyl_KD976298.1: exons 12-19). Both NtGnTI genes
were also annotated in NCBI database: NtGnTI.A (NCBI gene
ID: 107789589) consists of 19 exons spanning on a 12.5 kb
genomic sequence (Figure 2A), while NtGnTI.B (gene ID:
107800221) is incomplete since the annotated contig covers only
the exons 1 to 10.
To compare the GnTI.A and GnTI.B genomic regions between
exons 11 and 12, genomic DNA was extracted from the three
Nicotiana plants as well as from BY-2 cells. Next, the GnTI region
spanning exons 6 to 15 was amplified using non-specific primers
[Ex6F and Ex15R] (Figure 2B). The expected 3.8 kb amplicon,
corresponding to GnTI.A, was detected for N. tomentosiformis,
N. tabacum and BY-2 cells. An 8.6 kb amplicon, corresponding to
GnTI.B, was detected for N. sylvestris and, although less intense,
for N. tabacum but not for BY-2 cells. Amplification of the region
1https://web.expasy.org/glycomod/
2https://solgenomics.net/organism/Nicotiana_tabacum/genome
spanning intron 8 to intron 12 was carried out using GnTI.B
specific primers [BIn8F and BIn12R] (Figure 2C). Sequencing
analysis showed that introns 11 of NtGnTI.B (Supplementary
Figure 4) and NsGnTI.B were 5.4 kb long, while introns 11
of NtGnTI.A and NtoGnTI.A were only 0.4 kb long. NtGnTI.A
and NtGnTI.B intron 11 sequences were aligned and the 5 kb
sequence specific to NtGnTI.B was blasted on the N. tabacum
TN90 genome. Two hundred fifty contigs (with an expect score
lower than 10−10) were identified, showing the presence of
numerous sequences highly similar to NtGnTI.B intron 11 in
the N. tabacum genome. In silico analysis of NtGnTI.B intron 11
sequence revealed the presence of three ORFs of 447, 183, and
507 codons (Supplementary Figure 4), which are associated with
the retrovirus-related Pol polyprotein from transposons TNT 1–
94, RE1 or RE2 from Vitis vinifera. Taken together, these results
suggest that the extended intron 11 in NtGnTI.B is due to a
transposition event.
To assess the expression of both NtGnTI orthologs, RNA
was extracted from the leaves of the three Nicotiana plants
and from BY-2 cells, and analyzed by RT-PCR, using primers
specific to each ortholog (Figure 2D). GnTI.A-specific primers
[AEx1F and AEx19R] amplified the expected 1.56 kb band
for N. tomentosiformis and N. tabacum plants as well as BY-2
cells. On the other hand, GnTI.B-specific primers [BEx1F and
BEx19R] only gave the expected 1.56 kb band for N. sylvestris and
N. tabacum plants but not for BY-2 cells. This is corroborated
by BY-2 cells RNAseq data (Ahmed et al., 2020) in which no
cDNA encoding GnTI.B was detected. The five GnTI cDNAs
were sequenced. The coding nucleotide sequences of NtGnTI.A
and NtGnTI.B from N. tabacum leaves were identical to the
N. tabacum cDNAs A4 and A9 already described in the
literature (Wenderoth and von Schaewen, 2000). In addition,
NtGnTI.A sequences obtained from N. tabacum leaves and BY-
2 cells were identical to the sequence identified in BY-2 cells
RNAseq data. Finally, the NsGnTI sequence was identical to
the database sequences (XM_009803697 and XM_009776507)
whereas NtoGnTI displayed a single mutation (Thr175Ala),
compared to the database sequence (XM_009610507).
Generation, Screening, and
Characterization of BY-2 GnTI-KO Cell
Lines
Four guide RNAs (gRNAs) were designed to inactivate both
NtGnTI.A and NtGnTI.B by targeting exons 1, 3, 13, and 14
(Supplementary Table 2). A transfer RNA (tRNA) was placed
before each gRNA to generate a polycistronic tRNA-gRNA
(GnTI.PTG). Once the PTG is transcribed, individual gRNAs
are expected to be released by the endogenous tRNA processing
machinery (Xie et al., 2015). The GnTI.PTG construct was
cloned into a pPAM plasmid containing a plant codon-optimized
Cas9 (Jansing et al., 2019) to generate the pPAM-GnTI-KO
plasmid (Figure 1A and Supplementary Figure 2). BY-2 cells
were transformed with the pPAM-GnTI-KO construct using
biolistics. After selection on kanamycin-supplemented medium,
36 transgenic lines were screened for N-glycosylation profile
modification. The extent of complex N-glycan suppression was
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FIGURE 2 | Characterization of Nicotiana GnTI genes. (A) Schematic representations of NtGnTI.A and NtGnTI.B genomic sequences. Black rectangles: exons; gray
rectangles: 3′UTR; horizontal arrows: primers; vertical arrows: guide RNA target sites; dotted line: interrupted genomic sequence. Note that intron 11 is extended in
NtGnTI.B. (B) PCR amplification of genomic DNA with the non-specific GnTI primers [Ex6F and Ex15R]. Bands are expected at 3.8 kb (GnTI.A) and 8.6 kb (GnTI.B).
(C) PCR amplification of genomic DNA with GnTI.B-specific primers [BIn8F and BIn12R]. GnTI.B-specific amplification band is detected at 7.2 kb. (D) PCR
amplification of cDNAs with GnTI.A and GnTI.B-specific primers [(A/B)Ex1F and (A/B)Ex19R]. The amplicon size is 1.56 kb. N.to: N. tomentosiformis; N.sy:
N. sylvestris; N.ta: N. tabacum.
first assessed by analyzing the N-glycosylation profile of the
proteins secreted in the culture medium by Western blotting
combining antibodies recognizing β1,2-xylose and α1,3-fucose
epitopes. Complete inactivation of GnTI by genome editing was
expected to suppress the synthesis of all complex N-glycans and
thereby incorporation of β1,2-xylose and α1,3-fucose residues.
Thirty-one out of 36 cell lines showed a dramatic and similar
reduction of complex N-glycan-associated signal as compared
with the WT cell line (Supplementary Figure 5 and data not
shown). However, none of the cell lines displayed a total absence
of signals as observed for the XylT/FucT-KO cell line used as a
control (Mercx et al., 2017). Four GnTI-KO lines (GnTI-KO#2,
23, 27, 30) were further analyzed using either anti-β1,2-xylose
or anti-α1,3-fucose antibodies (Figure 3A). While no signal
corresponding to β1,2-xylose could be detected, an α1,3-fucose-
specific signal was detected in all four GnTI-KO lines, but with
a 30 to 100-fold lower intensity compared with the WT cell
line. Similar results were obtained when TSCPs were analyzed by
Western blotting (Figure 3B).
Generation, Screening, and
Characterization of GnTI/FucT-KO Cell
Lines
To suppress both GnTI and FucT activities, the GnTI.PTG
genetic construct was combined with the FucT.PTG construct
previously used to obtain the XylT/FucT-KO cell line (Mercx
et al., 2017) into a pPZP-RCS2 binary plasmid containing the
plant codon-optimized cas9 (Figure 1B and Supplementary
Figure 3). This plasmid is referred to as pPZP-GnTI/FucT-KO
and was used to transform WT BY-2 via A. tumefaciens co-
cultivation. Preference for Agrobacterium transformation was
guided by the need for precise genomic integration if further
T-DNA removal was needed, using the Cre-lox system. After
selection on kanamycin-supplemented medium, 22 GnTI/FucT-
KO cell lines were screened using the same immunoblotting
strategy as for GnTI-KO lines. Fifteen cell lines showed an
absence or strong reduction of β1,2-xylose and α1,3-fucose
combined signals on secreted glycoproteins (Supplementary
Figure 6 and data not shown). Four GnTI/FucT-KO cell lines
(#5, 10, 16, and 18) for which no signal had been observed were
chosen for further analysis. Secreted glycoproteins were analyzed
by Western blotting using either anti-β1,2-xylose or anti-α1,3-
fucose antibodies (Figure 4A). No β1,2-xylose nor α1,3-fucose
residues were detected in any of these lines. Analysis of the TSCPs
by Western blotting confirmed the absence of β1,2-xylose and
α1,3-fucose residues in glycoproteins of cell lines #5, 10, and 16
(Figure 4B), indicating the complete inactivation of both GnTI
and FucT genes. A faint signal for α1,3-fucose was observed in
cell line #18, suggesting that a minor residual FucT activity was
still present in that particular cell line.
Mass Spectrometry Analysis of Total
N-Glycans on Glycoproteins Secreted by
GnTI-KO#2 and GnTI/FucT-KO#10 Cell
Lines
Secreted glycoproteins of WT, GnTI-KO#2 and GnTI/FucT-
KO#10 cell lines were analyzed by MALDI-FT ICR mass
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FIGURE 3 | Absence of β1,2-xylose and reduction of α1,3-fucose on glycoproteins from the GnTI-KO BY-2 cell lines. Secreted proteins (40 µL culture medium) (A)
or total soluble cellular proteins (12.5 µg) (B) from a WT, XylT/FucT-KO, and the indicated GnTI-KO cell lines were separated by gel electrophoresis and analyzed by
Western blotting using anti-β1,2-xylose or anti-α1,3-fucose antibodies. Horseradish peroxidase-linked or phosphatase alkaline-linked secondary antibodies were
used for secreted proteins (A) and total soluble cellular proteins (B), respectively. A colloidal blue gel is displayed as a loading control.
spectrometry after 2-aminobenzamide reductive labeling to
determine their respective N-glycoprofile. Spectra are displayed
in Figure 5 and relative amounts of the N-glycan structures
are provided in Table 1. The N-glycoprofile of bovine RNAse B
was determined as a positive control (Supplementary Figure 7
and Supplementary Table 3). Fourteen N-glycan structures
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FIGURE 4 | Absence of β1,2-xylose and α1,3-fucose on glycoproteins from GnTI/FucT-KO lines. Secreted proteins (40 µL culture medium) (A) or total soluble
cellular proteins (12.5 µg) (B) from WT, XylT/FucT-KO, GnTI-KO#2, and the indicated GnTI/FucT-KO cell lines were separated by gel electrophoresis and analyzed
by Western blotting using anti-β1,2-xylose or anti-α1,3-fucose antibodies. Horseradish peroxidase-linked or phosphatase alkaline-linked secondary antibodies were
used for secreted proteins (A) and total soluble cellular proteins (B), respectively. A 50-fold dilution of WT proteins (equivalent to 0.8 µL culture medium or 0.25 µg
TSCPs) were loaded in the penultimate well (WT 1/50). A colloidal blue gel is displayed as a loading control.
were detected on the secreted glycoproteins of WT BY-2 cells.
The most abundant structures were GnMXF (27.9%), GnGnXF
(20.9%), and GnMX (14.6%). Complex, paucimannosidic and
hybrid N-glycans accounted for 84.8% of the N-glycans on
proteins secreted in WT BY-2 cells. High-mannose N-glycans
made up for only 15.2% of the N-glycans. GnTI inactivation
resulted in a dramatic shift toward high-mannose N-glycan
structures in GnTI-KO#2 and GnTI/FucT-KO#10 lines, in
which they accounted for 98.4% and 99% of the N-glycans,
respectively. Only six N-glycan structures, corresponding to
Man3-8 were identified in the KO lines. The main N-glycan
structures detected in GnTI-KO#2 and GnTI/FT-KO#10 were
Man5 (79.7 and 85.9%, respectively) and Man4 (16.4 and
11%, respectively).
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FIGURE 5 | Total 2-aminobenzamide labeled N-glycans released from secreted glycoproteins of indicated cell lines. Peaks identified as N-glycan signals are labeled.
Signals were detected as singly positively charged [M + H]+ or [M + Na]+ using MALDI FT-ICR mass spectrometry.
Genomic Analysis of
CRISPR/Cas9-Induced Indels in
GnTI-KO#2 and GnTI/FucT-KO#10 Cell
Lines
To identify the Cas9-mediated editing of the GnTI alleles,
genomic DNA was extracted from WT, GnTI-KO#2, and
GnTI/FucT-KO#10 cell lines. The GnTI region encompassing the
four targeted loci (exon 1 to exon 14) was PCR-amplified using
primers hybridizing to conserved regions [Ex1F and Ex15R]
(Figure 2A). Gel electrophoresis showed amplicons of the same
expected size (7.6 kb) for WT, GnTI-KO#2, and GnTI/FucT-
KO#10 cell lines as well as an extra smaller amplicon (0.44 kb)
for GnTI/FucT-KO#10 (Figure 6A). Amplicons were cloned and
eight different GnTI.A alleles in GnTI-KO#2 line and two in
GnTI/FucT-KO#10 were identified by sequencing (Figure 6B).
No GnTI.B amplicon could be obtained due to the presence of
the large 5.4 kb intron 11. To obtain amplicons corresponding
to GnTI.B, two separate PCR amplifications were carried out
to get regions corresponding either to sites 1–2 using primers
[Ex1F and In3R] or to sites 3–4 using primers [In12F and Ex15R]
(Figure 2A). Amplification of sites 1–2 resulted in obtaining
GnTI.A sequences exclusively, whereas amplification of sites 3–
4 gave both GnTI.A and GnTI.B sequences. Three GnTI.B alleles
were identified for GnTI-KO#2 and one for GnTI/FucT-KO#10
(Figure 6B). Sequence analysis confirmed that these alleles were
effectively inactivated. Indeed, three out of the four target sites
were mutated in GnTI.A allele 4 while all other GnTI.A and
GnTI.B alleles were modified at each observed target site. Most
GnTI-KO#2 indels consisted of small insertions or deletions
but a deletion of 180 nucleotides occurred between sites 3 and
4 in GnTI.A alleles 1, 3, and 7. The presence of more than
four alleles indicates that some indels were not induced in the
initial A. tumefaciens-transformed BY-2 cell, but later on in
daughter cells. The largest deletion was observed for GnTI/FucT-
KO#10 cell line. Indeed, the small 0.4 kb amplicon observed in
gel electrophoresis (Figure 6A) corresponds to GnTI.A allele 2,
which underwent a 7.16 kb deletion between sites 1 and 4. All
sequences obtained forGnTI.B sites 3–4 using primers [In12F and
Ex15R] correspond to allele 3, suggesting homozygous mutation.
FucT/GnTI-KO#10 cell line was likely homogeneous since each
GnTI ortholog was present in one or two mutated versions.
DISCUSSION
In this study, we inactivated the two GnTI genes in
N. tabacum BY-2 suspension cells using CRISPR/Cas9
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TABLE 1 | Relative amounts of total 2-aminobenzamide labeled N-glycans (%) decorating the secreted glycoproteins from WT and KO cell lines as determined by MALDI
FT-ICR mass spectrometry.
Glycan type Composition Putative structure Abbreviation1 Relative amounts2
WT GnTI-KO#2 GnTI/FucT-KO#10
Oligomannose HexNAc2Hex9 Man9 0.4% ND3 ND
HexNAc2Hex8 Man8 1.4% 0.8% 0.6%
HexNAc2Hex7 Man7 1.7% 0.4% 0.6%
HexNAc2Hex6 Man6 5.6% 1.2% 1.0%
HexNAc2Hex5 Man5 5.0% 79.7% 85.9%
HexNAc2Hex4 Man4 1.1% 16.4% 11.0%
Paucimannose HexNAc2Hex3 MM 1.7% 1.6% 1.0%
HexNAc2Hex3Pent1 MMX 3.4% ND ND
HexNAc2Hex3dHex1Pent1 MMXF 7.0% ND ND
Complex HexNAc3Hex3Pent1 GnMX 14.6% ND ND
HexNAc3Hex3dHex1Pent1 GnMXF 27.9% ND ND
HexNAc3Hex2dHex1Pent1 N/A4 0.4% ND ND
HexNAc4Hex3Pent1 GnGnX 8.9% ND ND
HexNAc4Hex3dHex1Pent1 GnGnXF 20.9% ND ND
1According to the nomenclature (Proglycan short) from http://www.proglycan.com. Gn, N-acetylglucosamine; M/Man, mannose; X, xylose; F, fucose. 2Relative amounts
were determined by considering only the absolute intensities of the peaks associated to an N-glycan structure. 3Not detected. 4Not assigned.
FIGURE 6 | Identification of CRISPR-induced indels in GnTI alleles from GnTI-KO#2 and GnTI/FucT-KO#10 BY-2 cell lines. (A) PCR amplification of GnTI.A from
genomic DNA extracted from the indicated cell lines, using primers [Ex1F and Ex15R]. (B) Sequences of the GnTI target sites. Colored nucleotides correspond to the
gRNA-hybridizing sites. PAM sequences are in bold. CRISPR-Cas9-induced deletions are represented by red dashes, insertions by red nucleotides. Single
nucleotide polymorphisms allowing distinguishing GnTI.A from GnTI.B alleles are highlighted in yellow.
gene edition in order to generate a cell line producing
only high-mannose N-glycans. GnTI has indeed a key
role in the formation of N-glycan diversity because it is
responsible for the addition of a first GlcNAc, on the α1,3-
arm. Addition of this particular residue on a Man5 is
considered as a prerequisite before being further modified
by Golgi α-mannosidase II, N-acetylglucosaminyltransferase
II, β1,2-xylosyltransferase, and α1,3-fucosyltransferase to
form hybrid, complex and paucimannosidic N-glycans
(Strasser et al., 2007).
To efficiently knock out GnTI in BY-2 cells, we first
characterized both NtGnTI orthologs. However, NtGnTI.B
exons 1–11 were detected in N. tabacum leaf material but
not in BY-2 cells. This suggests that genome modifications
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impacting the first half of GnTI.B occurred in this cell line.
It is known that plant suspension cells, including BY-2,
might be genetically unstable and subjected to chromosome
rearrangements (Kovarik et al., 2012). To guarantee the
inactivation of both genes, two pairs of gRNAs targeting the first
(exons 1 and 3) and second halves (exons 13 and 14) of GnTI.A
and GnTI.B were designed.
Complete inactivation of GnTI was expected to result in a cell
line producing only high-mannose N-glycans. Western blotting
analysis of secreted proteins from the GnTI-KO cell lines showed
absence of β1,2-xylose residues and an extensive reduction (30-
to-100-fold) of α1,3-fucose residues as compared to WT secreted
proteins. Absence of N-glycans containing β1,2-xylose residues
demonstrates the suppression of the entire GnTI activity since
GnTI-processed N-glycans would be recognized as substrates
by Golgi-resident glycosyltransferases like xylosyltransferases
(Strasser et al., 2004b; Kaulfurst-Soboll et al., 2011). Genomic
analysis of the GnTI-KO#2 cell line confirmed the GnTI
inactivation since all GnTI alleles sequenced contained Cas9-
induced indels. Complete suppression of α1,3-fucose residues
was required because their elimination is desirable to produce
glycoproteins lacking non-human epitopes susceptible to trigger
allergenic response (van Ree et al., 2000; Altmann, 2007; Gomord
et al., 2010). To remove the residual α1,3-fucose, combined
inactivation of the two GnTI and the four FucT genes (twelve
alleles) was carried out to generate GnTI/FucT-KO cell lines.
Secreted and soluble intracellular proteins of three GnTI/FucT-
KO cell lines (#5, #10, and #16) were totally devoid of any
β1,2-xylose and α1,3-fucose residues.
Mass spectrometry analysis of N-glycan structures of secreted
glycoproteins from WT, GnTI-KO#2 and GnTI-FucT-KO#10
lines identified the major changes that occurred in the KO
lines. While most N-glycans in the WT cell line were of
complex type, none were detected in either of the KO lines.
Man4 and Man5 structures accounted for 96.1 and 96.9%
of the N-glycans in the GnTI-KO#2 and GnTI-FucT-KO#10
cell lines, respectively. Unlike the Western blotting data, we
could not detect any fucosylated structure in the GnTI-
KO#2 cell line. However, this can be explained by the fact
that the α1,3-fucose signal observed by Western blotting in
GnTI-KO#2 cell line was very weak. It probably belongs to
fucosylated N-glycans distributed between different masses.
Their individual MS signal drops below the detection limit of
the method.
Detection of α1,3-fucose on N-glycans in GnTI-KO cell
lines was surprising and can only be explained by a relaxed
substrate specificity of FucTs, unlike what is usually reported in
the literature. Our hypothesis is that at least one of the four
N. tabacum FucTs can recognize and process high-mannose
N-glycans, although with a lower rate than hybrid and complex
N-glycans. The lack of high-mannose N-glycans with α1,3-
fucose reported in most plant and plant cell studies is probably
due to their very low levels. It could also be correlated with
a higher affinity of FucTs for complex N-glycans. However,
detection of Man5F N-glycans on human glucocerebrosidase
and α-iduronidase produced in the A. thaliana seeds of the
conditional cgl1-1 mutant has been reported several times (He
et al., 2011; He et al., 2013; Pierce et al., 2017). The authors
linked the presence of Man5F to hexosaminidase activities on
the hybrid structure GnMan5F. However, it is highly unlikely
that only Man5F would be detected if this structure resulted
from hexosaminidase processing. Indeed, neither GnMan5
with or without xylose or α1,3-fucose nor the corresponding
hexosaminidase-processed structures Man5XF and Man5X were
detected in these studies. We rather suggest that the Man5F
N-glycan observed in the GnTI-deficient host was not the result
of hexosaminidase activity but the product of the α1,3-FucT-
catalyzed addition of a core fucose on some Man5 N-glycan
structures present in very large amount because GnTI was
absent. Similar loose substrate specificity was described for the
mammalian core α1,6-fucosyltransferase (FUT8). Core α1,6-
fucosylation by FUT8 in mammals was first believed to be
strictly GnTI-dependent because α1,6-fucosylated N-glycans
identified by mass spectrometry were for the overwhelming
majority hybrid or complex types. Furthermore, in vitro
studies showed that FUT8 requires the presence of an α1,3-
arm GlcNAc (but not an α1,6-arm GlcNAc) to use free
N-glycans as substrates (Calderon et al., 2016). In contrast
to this result, in vivo observations showed that, in GnTI-
deficient CHO and HEK293S cells, high-mannose N-glycans
could be efficiently core-fucosylated (Lin et al., 1994; Crispin
et al., 2006). In addition, recent in vitro Man5 fucosylation
assays, using protein- or peptide-linked N-glycans instead
of free N-glycans showed that protein- and peptide-linked
Man5 could be fucosylated to some extent, according to the
glycopeptide or glycoprotein (Yang et al., 2017). We propose
a similar loose substrate specificity of some plant α1,3-FucTs
for Man5.
GnTI-KO and GnTI/FucT-KO BY-2 cell lines produced
highly homogeneous glycoproteins secreted in the culture
medium with only two main N-glycan structures (Man4 and
Man5). This N-glycoprofile is strongly recommended for some
therapeutic glycoproteins (Grubb et al., 2010; He et al., 2011;
He et al., 2013; Tekoah et al., 2015; Limkul et al., 2016;
Pierce et al., 2017). Furthermore, a high N-glycan homogeneity
can ease the protein purification as well as the process
reproducibility, leading to more consistent therapeutic efficacy
(Meuris et al., 2014). As a result, the development of a BY-2
production platform with simplified and homogenized N-glycan
repertoire, such as the humanized XylT/FucT-KO cell lines
(Hanania et al., 2017; Mercx et al., 2017) or the two glyco-
engineered cell lines generated in this study, is an important
step to produce highly efficient therapeutic glycoproteins and
simplify vaccine production in a system free of potential
mammalian pathogens.
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